Neuroendocrine tumor of the colon, well differentiated, low or intermediate grade tumor

Summary

Neuroendocrine tumor of the colon, well differentiated, low or intermediate grade tumor (MONDO:0015067) is a cancer and 1 clinical trial. A subtype of digestive system neuroendocrine tumor, grade 1/2 — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	neuroendocrine tumor of the colon, well differentiated, low or intermediate grade tumor
Mondo ID	MONDO:0015067
NCIT	C135212
UMLS	C4525742
MedGen	1617490
GARD	0025057
Anatomy (UBERON)	UBERON:0001155
Is cancer (heuristic)	yes

Also known as: carcinoid tumor of colon · carcinoid tumour of colon · colon neuroendocrine tumor · colon neuroendocrine tumour · colonic NET · NET of the colon · neuroendocrine neoplasm of the colon

Disease family

This is a subtype of digestive system neuroendocrine tumor, grade 1/2. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system neuroendocrine neoplasm › digestive system neuroendocrine tumor, grade 1/2 › neuroendocrine tumor of the colon, well differentiated, low or intermediate grade tumor

Related subtypes (9): small intestine neuroendocrine tumor, well differentiated, low or intermediate grade, gastrin-producing neuroendocrine tumor, esophageal neuroendocrine tumor, L-cell glucagon-like peptide-producing neuroendocrine tumor, gastric neuroendocrine tumor, well differentiated, low or intermediate grade, rectal neuroendocrine tumor, gallbladder neuroendocrine tumor, grade 1/2, pancreatic neuroendocrine tumor, intestinal neuroendocrine tumor G1

Subtypes (3): colonic L-cell glucagon-like peptide producing tumor, colon neuroendocrine tumor G1, neuroendocrine tumor of the appendix, well differentiated, low or intermediate grade

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04907643	Not specified	RECRUITING	Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes